
|Videos|August 13, 2014
Treating a Patient With HER2-Negative Metastatic Breast Cancer
Author(s)Linda D. Bosserman, MD, FACP
Linda D. Bosserman, MD, FACP, president, medical oncologist, Wilshire Oncology Medical Group, discusses how she would treat a patient with HER2-negative metastatic breast cancer.
Linda D. Bosserman, MD, FACP, president, medical oncologist, Wilshire Oncology Medical Group, discusses how she would treat a patient with HER2-negative metastatic breast cancer.
This segment is a part of our Case-Based Peer Perspectives.View the case details > >



















